Literature DB >> 3411655

Long-term followup in 1,003 extracorporeal shock wave lithotripsy patients.

J Graff1, W Diederichs, H Schulze.   

Abstract

We evaluated 1,003 patients treated with extracorporeal shock wave lithotripsy after a mean followup of 19.1 months (range 12 to 26 months). Followup excretory urograms were normal in 97 per cent of the patients. Two-thirds of the patients reported further discharge of residual fragments, mainly during the first 3 months. Rehospitalization was necessary in 57 patients. Over-all, the rate free of stones after followup was 72.2 per cent and it was not different for primary and recurrent stone patients. Rates free of stones were influenced mainly by the primary stone location and the number of stones in a renal unit. Patients with lower caliceal stones had a rate without calculi of only 57.8 per cent. Almost identical results were obtained for stones other than in the lower calix, when fragments were found in the lower calix at the time the patient was discharged from the hospital. The pre-treatment stone volume, as determined by measuring the stone area in square millimeters, did not influence the final rates free of stones for calculi up to 400 mm.2, that is 2.4 cm. of a sphere. Only calculi larger than 400 mm.2 showed an inverse relationship to the final rate free of stones. Multiple stones yielded a success rate of 64 per cent, with 90 per cent of the patients having regrowth of residual fragments. Serious complications during followup were not encountered.

Entities:  

Mesh:

Year:  1988        PMID: 3411655     DOI: 10.1016/s0022-5347(17)41696-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  Dexmedetomidine-ketamine and midazolam-ketamine combinations for sedation in pediatric patients undergoing extracorporeal shock wave lithotripsy: a randomized prospective study.

Authors:  Senem Koruk; Ayse Mizrak; Rauf Gul; Ertugrul Kilic; Fatih Yendi; Unsal Oner
Journal:  J Anesth       Date:  2010-10-06       Impact factor: 2.078

2.  Sciaticum majus foramen and sciaticum minus foramen as the path of SWL in the supine position to treat distal ureteral stone.

Authors:  Jianlin Lu; Xizhao Sun; Lei He
Journal:  Urol Res       Date:  2010-07-13

3.  Pelvi-calyceal height, a predictor of success when treating lower pole stones with extracorporeal shockwave lithotripsy.

Authors:  A Symes; G Shaw; D Corry; S Choong
Journal:  Urol Res       Date:  2005-06-04

4.  The impact of radiological anatomy in clearance of lower caliceal stones after shock wave lithotripsy.

Authors:  Mustafa Ozgür Tan; Lokman Irkilata; Ilker Sen; Metin Onaran; Bora Küpeli; Ustünol Karaoğlan; Ibrahim Bozkirli
Journal:  Urol Res       Date:  2007-04-20

5.  Treatment of Renal Calculi with Extracorporeal Shock Wave Lithotripsy: How applications of this method have expanded.

Authors:  P M Eberwein; J D Denstedt
Journal:  Can Fam Physician       Date:  1992-07       Impact factor: 3.275

Review 6.  The recurrence rate of stones following ESWL.

Authors:  K U Köhrmann; J Rassweiler; P Alken
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

7.  Retrograde transureteral approach: a safe and efficient treatment for recurrent cystine renal stones.

Authors:  Lorenzo Ruggera; Martina Zanin; Paolo Beltrami; Filiberto Zattoni
Journal:  Urol Res       Date:  2010-12-31

8.  Efficacy of extracorporeal shock wave lithotripsy for ureteric stones in children.

Authors:  Ahmet Yaser Muslumanoglu; Ahmet Hamdi Tefekli; Fatih Altunrende; Mert Ali Karadag; Murat Baykal; Muzaffer Akcay
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

9.  Outcomes of Shock Wave Lithotripsy and Ureteroscopy for Treatment of Pediatric Urolithiasis.

Authors:  Rohit Tejwani; Hsin-Hsiao S Wang; Steven Wolf; John S Wiener; Jonathan C Routh
Journal:  J Urol       Date:  2016-03-17       Impact factor: 7.450

10.  Modern management of stone disease in patients with a solitary kidney.

Authors:  Maciej Kupajski; Michał Tkocz; Damian Ziaja
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2011-11-09       Impact factor: 1.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.